Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-05-11ALLR3Initial Statement of Beneficial Ownership
Jesper Hoeiland, a director at Allarity Therapeutics, Inc. (ALLR), filed an initial statement of beneficial ownership on May 11, 2026, reporting ownership as of June 10, 2025. The filing indicates that Mr. Hoeiland does not directly own any securities of the company. This statement is made in accordance with regulatory...
Nano CapBiotechnology
2026-05-11ATRA3Form 3 Filing by EcoR1 Capital, LLC and related parties for Atara Biotherapeutics, Inc.MEDIUM
This filing is a Form 3, which reports initial beneficial ownership of securities. EcoR1 Capital, LLC, along with its affiliated fund Qualified Fund and its manager Oleg Nodelman, are the reporting persons. They jointly report beneficial ownership of 1,044,593 shares of Atara Biotherapeutics, Inc. Common Stock. Qualifi...
Micro CapBiotechnology